Funding for this research was provided by:
Ovarian Cancer Research Fund (327679)
Roswell Park Alliance Foundation, Roswell Park Cancer Institute
National Institutes of Health (1R01CA158318-01A1)
New York State Department of Health (C030158)
Text and Data Mining valid from 2019-01-09
Received: 24 July 2018
Accepted: 28 November 2018
First Online: 9 January 2019
Ethics approval and consent to participate
: Animal experiments were performed in accordance with an approved protocol from the Institutional Animal Care and Use Committee at Roswell Park Comprehensive Cancer Center. Biospecimens of epithelial ovarian cancer patients were obtained with informed consent at Roswell Park Comprehensive Cancer Center in accordance with a protocol approved by the institutional review board.
: Not applicable
: JM, TT and KO are inventors of a patent application by Roswell Park Comprehensive Cancer Center regarding the TCR genes. Other authors have no conflict of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.